graph EGM comparisons
pembrolizumab (10mg/kg)titlenivolumab alonetitlepembrolizumab (10mg/kg) 2 weekstitlepembrolizumab (2mg/kg)titleStandard of Care (SoC)titleipilimumab alonetitleCheckMate 037, 2015 NCT01721746 mML - L2 - all population 272/133KEYNOTE-006 (3 week), 2015 NCT01866319 mML - L2 - all population 277/278KEYNOTE-002 (10 mg/kg), 2015 NCT01704287 mML - L2 - all population 181/179KEYNOTE-006 (2 week), 2015 NCT01866319 mML - L2 - all population 279/278KEYNOTE-002 (2 mg/kg), 2015 NCT01704287 mML - L2 - all population 180/179

Pathology:  mML - L2 - all population; 

mML - L2 - all population
CheckMate 037, 2015KEYNOTE-006 (3 week), 2015KEYNOTE-002 (10 mg/kg), 2015KEYNOTE-006 (2 week), 2015KEYNOTE-002 (2 mg/kg), 2015
pembrolizumab (10mg/kg)2T1T1
nivolumab alone1T1
pembrolizumab (10mg/kg) 2 weeks1T1
pembrolizumab (2mg/kg)1T1
Standard of Care (SoC)0T0T0T0
ipilimumab alone0T0T0